CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) (USD $)	6 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Cash flows from operating activities :
Net income (loss)	$ (310)	$ 425
Adjustments to reconcile net loss to net cash used in operating activities :
Depreciation and amortization expense	111	102
Gain on CADRA sale	(91)	0
Stock-based compensation	4	4
Non-cash interest expense	6	0
Change in fair value of warrant liability	(6)	0
Change in Current assets and liabilities:
Accounts receivable.	(196)	(303)
Prepaid expenses and other assets	159	48
Restricted cash	1,306	0
Accounts payable, accrued expenses and other liabilities	402	(2)
Deferred maintenance revenue	(538)	(630)
Net cash used in operating activities	(1,765)	(356)
Cash flows from investing activities:
Proceeds from sale of product line, net of direct cash expenses	2,432	0
Capital expenditures	(37)	(2)
Capitalized software development costs	(57)	(159)
Capitalized patent costs	(2)	(6)
Net cash (used in)provided by investing activities	2,336	(167)
Cash flows from financing activities :
Cost of treasury shares	(63)	0
Capitalized debt issuance costs	(32)	0
Proceeds from issuance of redeemable common stock, net of issuance costs	0	98
Repayment under debt agreements	0	(360)
Borrowing under debt agreements	0	300
Repayments under capital lease	(8)	(4)
Net cash provided by financing activities	(103)	34
Effect of exchange rates on cash	(44)	3
Increase (decrease) in cash and cash equivalents	424	(486)
Cash and cash equivalents at beginning of period	1,188	595
Cash and cash equivalents at end of period	1,612	109
Supplemental Disclosures of Cash Flow Information:
Interest Paid	153	84
Income taxes Paid	14	2
Noncash investing and financing activities:
Issuance of warrants	51	0
Purchase of property and equipment under capital lease	0	53
Accretion of redeemable common stock	$ 0	$ 36